Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new 'Study Status' entry to the record history and updated the latest version indicator to 10. The 2025-12-15 entry was removed from the history.SummaryDifference0.4%

- Check31 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded revision v3.4.3 to the history and removed revision v3.4.2.SummaryDifference0.1%

- Check66 days agoChange DetectedThe history now shows a new revision entry for v3.4.2 and the government funding operating-status notice was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check74 days agoChange DetectedA government funding lapse notice was added to the page, and the revision was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.